Mechanism of Action
Gonadorelin is a synthetic decapeptide that binds to GnRH receptors on the anterior pituitary gland. This binding activates intracellular signaling pathways that lead to the synthesis and release of the gonadotropins, LH and FSH. The natural release of GnRH is pulsatile, and the response to gonadorelin depends on the pattern of administration.
In research settings, gonadorelin is used to study the hypothalamic-pituitary-gonadal (HPG) axis and the dynamics of LH and FSH secretion.
Clinical and Research Context
Gonadorelin is also used in diagnostic tests to assess pituitary function and in certain therapeutic protocols under medical supervision. In research, it serves as a tool to investigate the regulation of reproductive hormone secretion.
Dragon Pharma Gonadorelin 10 mg is supplied as a lyophilized powder in a 2 mL vial at a labeled strength of 10 mg/vial.
Medical and Research References
Gonadorelin has been studied in clinical and research contexts. Authoritative sources provide information on its pharmacology and physiological effects.